Pediatrics Doctors in Westbrook, ME Accepting Medicare

4 Pediatrics doctors found. Showing 1 - 4

Lucy Morgan Amory, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Harnois Ave, Westbrook, ME 04092 Phone: 207-662-1360

Jane Ho, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Harnois Ave, Westbrook, ME 04092 Phone: 207-662-1360    Fax: 207-662-1361

Dr. John Michael Girard, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Harnois Dr, Westbrook, ME 04092 Phone: 207-662-1360    Fax: 207-662-1361

Genevieve S Whiting, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Harnois Ave, Suite 1a, Westbrook, ME 04092 Phone: 207-662-1360    Fax: 207-662-1361

News Archive

BAP releases new guidelines on treatments for sleep disorders

Insomnia and other sleep disorders are very common, yet are not generally well understood by doctors and other health care professionals. Now the British Association for Psychopharmacology (BAP) has released up-to-the-minute guidelines in the Journal of Psychopharmacology, published by SAGE, to guide psychiatrists and physicians caring for those with sleep problems.

Study links COVID-19 to multisystem inflammatory syndrome in children

At the height of the COVID-19 pandemic in April, a 14-year-old boy was admitted to the emergency department at Nemours Children's Health System in Delaware with mysterious symptoms in what would later be identified as one of the first cases of multisystem inflammatory syndrome in children (MIS-C) in the U.S.

Human migration study reveals new insights into cancer metastasis

What could cancer cells and drug-resistant bacteria possibly have in common with Stone Age settlers of the Americas? They're all migratory, and at one time or other, each finds the going a bit easier in a specific direction.

Lantheus Medical Imaging supports FDA action to ensure appropriate use of gadolinium-based contrast agents

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, supports the U.S. Food and Drug Administration's (FDA) announcement requiring safety-related label changes for all gadolinium-based contrast agents to highlight the rare and potentially fatal condition known as nephrogenic systemic fibrosis (NSF).

Read more Medical News

› Verified 1 days ago